A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Trial Profile

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2017

At a glance

  • Drugs Tumour necrosis factor-alpha kinoid (Primary) ; Montanide ISA-51
  • Indications Rheumatoid arthritis
  • Focus Biomarker; Therapeutic Use
  • Sponsors Neovacs
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Mar 2015 Results published in a Neovacs media release.
    • 27 Feb 2015 Primary endpoint (Change in DAS28-CRP between Month 6 and baseline) has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top